Disease-modifying treatment and disability progression in subclasses of patients with primary progressive ms: results from the big ms data network

HIGHLIGHTS

• What: WHAT THIS STUDY ADDS ⇒ This study shows that people with PPMS can be classified by their disability trajectories. Given the study design, the authors were not able to stratify the analysis for the presence of relapses during the prospective follow-­up time, as this would have introduced conditioning on future events. The focus of the analysis was to explore whether patients with different disability trajectories might respond differently to immunomodulatory treatment.
• Who: Multiple sclerosis et al. from the Author , Department of Neurology, University Hospital Basel, Basel, Switzerland , Research Center for Clinical Neuroimmunology and Neuroscience . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.